From Name:
From Email:
To Name:
To Email:

Optional Message:


Pertuzumab approved for HER2 breast cancer

from Medscape Medical News

A new drug that targets HER2-positive breast cancer, pertuzumab, has been approved in the United States. About one quarter of all cases of breast cancer are HER2-positive. Pertuzumab is approved for use in combination with the first HER2 therapy ever launched, trastuzumab, and with the chemotherapy agent docetaxel. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063